Anticoagulants, renal failure and atrial fibrillation

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.1, 2013-01, pp. : 1-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. : 6096-6105

Bentham Science Publishers

Access to resources Recommend Favorite

Apixaban: Effective and Safe in Preventing Thromboembolic Events in Patients with Atrial Fibrillation and Renal Failure

Current Medicinal Chemistry, Vol. 24, Iss. 34, 2017-11 ,pp. : 3813-3827

Bentham Science Publishers

Access to resources Recommend Favorite

New Anticoagulants for Stroke Prophylaxis in Atrial Fibrillation: Assessing the Impact on Medication Adherence

By Kopecky Stephen

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 287-294

Adis International

Access to resources Recommend Favorite

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim Schott Gisela

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite

Valsartan reduces risk of atrial fibrillation in heart failure

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite